Subscribe To
Best income stocks to buy for october 9th
GPRK and LW made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 9, 2023....
Draftkings: incredible execution justifies rally
DraftKings' stock price has nearly tripled this year, driven by strong fundamental wins and positive Q2 results. The company still has room to capture...
Birkenstock to ipo at top end of valuation on wednesday - report
Birkenstock Holding is expecting to price its IPO at the top end of its range after having garnered enough investor commitments to reach a $10 billion...
Bristol-myers squibb enahnces oncology portfolio in deal worth up to $5.8bn
Bristol-Myers Squibb Co (NYSE:BMY) has unveiled plans to buy Mirati Therapeutics (NASDAQ:MRTX) in a deal that values the cancer drug developer at up...
Texas instruments: a must-have in every dividend growth portfolio
Semiconductor companies' sales doubled from 2012 to 2022 due to the rising demand for digital products. Semiconductor industry experiences economic cy...
Metro bank shares open 19% higher after funding deal
Shares in Metro Bank opened 19% higher on Monday, after the embattled British lender struck a fundraising deal overnight to bolster its balance sheet....
Gsk inks £2.5bn shingles vaccine deal with china's zhifei
GSK PLC (LSE:GSK, NYSE:GSK) has inked an exclusive three-year agreement, £2.5 billion with China's Zhifei to co-promote its shingles vaccine in Chi...
Calix: promising company but remain cautious for now
Calix has a strong position in the market through its focus on network service levels and managed services. CALX is reshaping the broadband market wit...
Ferrari ceo vigna on fully electric model prototype
"I like it a lot." Ferrari NV Chief Executive Officer Benedetto Vigna shares his take on the prototype of the Italian luxury automaker's first fully ...
Hercules site services pens labour supply deal with balfour beatty
Hercules Site Services PLC (AIM:HERC) has announced a five-year contract to supply Balfour Beatty plc (LSE:BBY) with labour as part of a sweeping rail...
Iq-ai subsidairy secures second orphan drug designation
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF)'s subsidiary, Imaging Biometrics, has secured orphan drug designation from the US Food and Drug Administration for ...
Apollo, jb capital preparing bid for vodafone's spanish unit, expansion says
U.S.-based buyout fund Apollo Global Management is readying a bid with local fund JB Capital for the Spanish unit of telecom giant Vodafone , the Expa...
Marten transport: a great ride that's now over
Marten Transport's financial performance has started to weaken after a strong fiscal year in 2022. Revenue and profitability have declined in the curr...
Ilika lands grant as it looks to enhance goliath pilot production capabilities
Ilika PLC (AIM:IKA, OTCQX:ILIKF), a specialist in solid-state battery technology, has landed a £400,000 grant from the Automotive Transformation Fu...
Down 20%, yielding 3%; let texas instruments help you retire (early)
Texas Instruments is a dividend growth stock with a >3% dividend yield and a 15% 5-year dividend CAGR. TXN has a strong business model with robust com...
Chill brands inks deal for vapes to be sold in wh smith
Chill Brands Group PLC (LSE:CHLL, OTCQB:CHBRF) has announced a deal with WH Smith PLC (LSE:SMWH) to sell vape products in its stores. Some 150 WH Smit...
Cintas: shares dressed for success, remain expensive amid a powerful uptrend
Small and mid-sized companies in the industrials sector outperform tech-related sectors in 2023. Cintas is the leading provider of corporate uniform r...
Gsk signs shingles vaccine deal with china's zhifei for about $3 bln
GSK , on Monday, announced an exclusive partnership with China's Chongqing Zhifei Biological Products (Zhifei) for its shingles vaccine....
Pendragon: autonation reportedly ready to join bidding war for car dealer
Mike Manley, the British CEO of Florida-based AutoNation, is contemplating intervening in the £500 million acquisition of Pendragon Group (LSE:PDG) P...
Novartis leads funding round for uk alzheimer's specialist
UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing tre...
Gsk reportedly set to shake up r&d opertion
GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...
Barclays: major banks reportedly sitting out latest wave of buyouts
Major banks such as Bank of America and Barclays PLC (LSE:BARC) are showing reluctance to lead financing for riskier buyouts this year, concerned that...
Exxonmobil reportedly has sights set on $50bn pioneer resources
ExxonMobil Corporation is in discussions to acquire Pioneer Natural Resources (NYSE:PXD), marking what could be the oil giant's largest acquisition si...
United maritime: upgrading to buy on vastly improved charter rates and generous dividend
Over the past twelve months, United Maritime has sold all of the tanker vessels acquired in July 2022 at an aggregate gain of $48 million. The company...
Clarus: promising initiatives, but risks still present
The company's revenue decreased by 27.2%, and the operating loss (% of revenue) reached 0.3%. Declining real consumer incomes, price investments, and ...
Gold prices forecast: balancing middle east unrest with u.s. rate hike odds
Amid Middle East turmoil, XAU/USD gains underscore gold's dual role: a safe haven buoyed by geopolitical risks and tempered by strong U.S. data....
Lamar advertising: 6 reasons to be bullish but one big risk, hold
Lamar Advertising shares have fallen 14% in 2023 due to a rise in interest rates and a slowdown in advertising. Despite the near-term weakness, LAMR i...
Dpg: worth a look as the dust settles
Duff & Phelps Utility and Infrastructure Fund discount has expanded rapidly after their distribution cut earlier in the year. The discount on DPG's sh...
Eagle materials: building success in the construction industry
Eagle Materials operates in the building materials industry and has a predictable business with strong cash flow generation. EXP has a history of succ...
Eurobank ends state participation in its share capital
Eurobank said on Monday it ended the state's participation in its share capital market by repurchasing 1.4% of its shares from the country's bank bail...
Analyzing immatics' multi-faceted investment case
Immatics showcases a robust financial position and promising IMA203 TCR-T cell therapy for oncology with impressive safety and efficacy data. Risks in...
Uk joins europe's growing 'greenlash' with new pro-motorist policies
As the U.K. government ramps up concessions for motorists, Britain joins the fold of countries caught up in a political backlash against Europe's gree...
Lyra therapeutics' nasal matrix in focus: sniffing out opportunity
Lyra Therapeutics' LYR-220 shows promise in addressing chronic rhinosinusitis, targeting a patient demographic that doesn't respond to current treatme...
Humana: bullish rating thanks to strong financials and low valuation
Humana gets a Buy rating, agreeing with the bullish consensus from analysts, Wall Street, and the quant system. Bullish sentiment fueled by low valuat...
Oil prices forecast: middle east tensions, opec's stance fuel bullish tone
Amid Middle East tensions and Hamas strikes, Brent crude jumps 4.1%, highlighting oil's balance between geopolitics and economics....